Delivery Order SPE2DB20D6037-SPE2DB23FD0KY

Award Date 6/19/23
Potential Completion Date 6/20/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $1,125.46 contract is for the delivery of 4565228755! SUMATRIPTAN SUCCINATE, a pharmaceutical product, with a performance period through July 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of Sumatriptan Succinate, a prescription migraine medication, with a ceiling value of $1,590.86 and a performance period through November 15, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,669.58, is for the delivery of the pharmaceutical product Sumatriptan Succinate. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that allows the DLA to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,312.12, is for the delivery of Imitrex 6 mg/0.5 ml pen injections to support the recurring medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's broader indefinite delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,062.06, is for the delivery of the prescription drug Sumatriptan Succinate. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,478.66 and covers the delivery of Sumatriptan Succinate, a prescription medication, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS Pharmaceutical Group Inc. holds a larger single-award...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,504.99 contract was awarded on August 29, 2024 by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to provide SUMATRIPTAN SUCCINATE, a prescription pharmaceutical product, with a performance period through August 30, 2024. This award is under a larger indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,557.82 and covers the delivery of Sumatriptan Succinate, a prescription medication, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of November 15, 2024 and is not associated with any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,588.96, is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. The contract is a firm fixed-price delivery order with no set-aside designation. It is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,522.57 firm fixed-price contract is for the delivery of Sumatriptan Succinate, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA valued at $499,999,999. This IDC enables the DLA to issue delivery orders for a...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB23FD0KY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,301.50 firm fixed-price contract is for the delivery of SUMATRIPTAN 6 MG/0.5 ML INJECT 0.5ML medication, with a completion date of June 20, 2023. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support military health facilities worldwide. This contract does not have a set-aside designation.

Generated 10/23/24, 9:41 AM